InsidersTradesSigma
Total declarations
Companies
▲ Purchases (24 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by COLUMN GROUP L P. Officer active across 2 companies, notably Nurix Therapeutics, Inc.. In total, 28 filings have been logged. Total volume traded: €33.4m. The latest transaction was filed on 9 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations28 total
€12m951,684 shares@ €12.712836.2% of flow
Common Stock
SEC:0000899243-22-022212:0·
Ideal exit: 6 Mar 2023 (T+270)
€12m951,684 shares@ €12.712836.2% of flow
Common Stock
SEC:0000899243-22-022214:0·
Ideal exit: 6 Mar 2023 (T+270)
€400,91333,071 shares@ €12.12281.2% of flow
Common Stock
SEC:0000899243-22-021215:0·
Ideal exit: 27 Feb 2023 (T+270)
€400,91333,071 shares@ €12.12281.2% of flow
Common Stock
SEC:0000899243-22-021216:0·
Ideal exit: 27 Feb 2023 (T+270)
€749,75759,766 shares@ €12.54492.2% of flow
Common Stock
SEC:0000899243-22-020688:0·
Ideal exit: 25 Feb 2023 (T+270)
€749,75759,766 shares@ €12.54492.2% of flow
Common Stock
SEC:0000899243-22-020690:0·
Ideal exit: 25 Feb 2023 (T+270)
€245,58219,534 shares@ €12.5720.7% of flow
Common Stock
SEC:0000899243-22-020202:0·
Ideal exit: 20 Feb 2023 (T+270)
€245,58219,534 shares@ €12.5720.7% of flow
Common Stock
SEC:0000899243-22-020203:0·
Ideal exit: 20 Feb 2023 (T+270)
€214,65417,240 shares@ €12.4510.6% of flow
Common Stock
SEC:0000899243-22-019689:0·
Ideal exit: 18 Feb 2023 (T+270)
€214,65417,240 shares@ €12.4510.6% of flow
Common Stock
SEC:0000899243-22-019690:0·
Ideal exit: 18 Feb 2023 (T+270)
€250,38519,984 shares@ €12.52930.7% of flow
Common Stock
SEC:0000899243-22-019209:0·
Ideal exit: 13 Feb 2023 (T+270)
€250,38519,984 shares@ €12.52930.7% of flow
Common Stock
SEC:0000899243-22-019208:0·
Ideal exit: 13 Feb 2023 (T+270)
€1m86,110 shares@ €12.72023.3% of flow
Common Stock
SEC:0000899243-22-018849:0·
Ideal exit: 11 Feb 2023 (T+270)
€1m86,110 shares@ €12.72023.3% of flow
Common Stock
SEC:0000899243-22-018848:0·
Ideal exit: 11 Feb 2023 (T+270)
125,096 shares
Common Stock
SEC:0000899243-22-018401:0·
Ideal exit: 7 Feb 2023 (T+270)
125,096 shares
Common Stock
SEC:0000899243-22-018399:0·
Ideal exit: 7 Feb 2023 (T+270)
€831,49577,866 shares@ €10.67852.5% of flow
Common Stock
SEC:0000899243-22-018031:0·
Ideal exit: 5 Feb 2023 (T+270)
€831,49577,866 shares@ €10.67852.5% of flow
Common Stock
SEC:0000899243-22-018030:0·
Ideal exit: 5 Feb 2023 (T+270)
€821,58880,430 shares@ €10.21492.5% of flow
Common Stock
SEC:0000899243-22-017672:0·
Ideal exit: 3 Feb 2023 (T+270)
€821,58880,430 shares@ €10.21492.5% of flow
Common Stock
SEC:0000899243-22-017674:0·
Ideal exit: 3 Feb 2023 (T+270)
241,750 shares
Common Stock
SEC:0000899243-22-003320:0·
Ideal exit: 21 Oct 2022 (T+270)
241,750 shares
Common Stock
SEC:0000899243-22-003318:0·
Ideal exit: 21 Oct 2022 (T+270)
241,750 shares
Common Stock
SEC:0000899243-22-003320·
Ideal exit: 21 Oct 2022 (T+270)
241,750 shares
Common Stock
SEC:0000899243-22-003318·
Ideal exit: 21 Oct 2022 (T+270)
02,000,000 shares0
Common Stock
SEC:0000899243-21-018771·
25 of 28 declarations
About COLUMN GROUP L P
COLUMN GROUP L P is a significant shareholder of Nurix Therapeutics, Inc.
